Fort Lee, NJ -- (SBWIRE) -- 09/27/2017 -- Herborium Group, Inc. (OTCMKTS:HBRM), a Botanical Therapeutics Company and the provider of unique all botanical medicinal products (Botanical Therapeutics) that target dermatological issues such as acne, and other health and wellness concerns, is proud to announce today that AcnEase, the Company's unique all herbal, clinically tested acne treatment (www.acnease.com) is the Number 1 featured product in the Acne Category on the recently launched UrthMarket™ online platform (www.urthmarket.com).
UrthMarket™, the biggest GMO-Free healthy marketplace online, is a product of UrthBox. Based out of San Franciso California, UrthBox is committed to GMO-free, organic and all-natural products only and is currently the leading healthy and GMO-Free monthly snack food subscription service with thousands of members worldwide. Unlike other marketplaces that charge consumers anywhere from $59 - $140 a year in store access fees, UrthMarket has zero monthly or yearly memberships fees. Consumers are set to save millions of dollars a year, with free access to search, discover, share and purchase from the largest selection of healthy and GMO-free products available online including snacks, foods, beverages, supplements, personal care products and other goods.
As previously announced, Herborium is focused on expanding distribution of its current product line as well as the launch of additional brands in the all-natural, CBD, hemp and herbal based products market to take advantage of the global $385 billion herbal medicines and nutraceuticals market.
These efforts will be supported by our growing distribution relationship, upgraded Social Media Strategy and the Company's recently executed Regulation A funding for up to $700,000
AcnEase is 100% botanical, proprietary treatment for acne with 96% user success rate and an unprecedented safety profile. AcnEase is free of chemicals, hormones, preservatives, gluten, dairy, sugar and GMOs.
Named a top beauty pick by Cosmopolitan France in May 2016, AcnEase provides not only a breakthrough treatment for different types of acne but also award winning content (AcnEase Blog is a Winner of the Best Skincare Blog by Healthline for 3 consecutive years) focused on results-driven, life-changing information such as cutting edge educational data on acne, its treatment options, safety related issues, social impact of acne, and tips on coping with every day and special situation skincare problems.
About Herborium Group, Inc.
Herborium Group, Inc. is a Botanical Therapeutics company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, womens health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.
For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr, www.acneasesp.com, www.acnease.co.uk.
Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.